Brief: Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection

Altamira Therapeutics

01/12/2020 14:08

Dec 1 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL REPORTS POSITIVE IN VITRO EFFICACY DATA FOR
AM-301
IN PROTECTING AGAINST SARS-COV-2 INFECTION
    * AURIS MEDICAL HOLDING LTD - UP TO 99.4% REDUCTION OF VIRAL
TITER
IN HUMAN EPITHELIAL CELL CULTURE
    * AURIS MEDICAL HOLDING LTD - RESULTS SUGGEST POTENTIAL FOR
AM-301
NASAL SPRAY TO MITIGATE RISK OF SARS-COV-2 INFECTION
    * AURIS MEDICAL HOLDING LTD -  LOOK FORWARD TO TAKING AM-301
TOWARDS SUBMISSION OF REGULATORY APPLICATIONS IN 2021

Source text for Eikon:  ID:nGNX2SBkjJ 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))